When: Daily close below $227 on volume >15M (Bollinger lower band failure), OR Q3 miss with guidance reset, OR securities fraud inquiry escalation with material disclosure

Then: Downgrade to Sell

When: Close below $204 on volume >15M (July 22 swing low failure)

Then: Exit residual to zero

SELL (trim 30-50% of non-core tactical exposure, retain dividend-yield core position, keep 260 invalidation level)

• 30 to 50 percent trim of non-core tactical exposure is the structurally correct compromise preserving optionality in both directions while reducing gross exposure
• 260 stop-loss is a clearly defined invalidation level that lets the trade breathe through basing pattern dead-cat bounces without engineering guaranteed stop-outs
• 2.87 percent dividend yield backed by $12 billion in free cash flow with coverage at 1.8 times FCF represents real cash compounding annually
• Net debt up 34 percent to $54.8 billion, working capital negative $7.5 billion, current ratio 0.79, goodwill at 49 percent of total assets are legitimate deterioration signals but not distress indicators
• Net debt to EBITDA at 3.3 times is elevated but manageable for investment-grade enterprise with $16+ billion EBITDA and decades of debt service history
• IBM stock at 233.87 represents 15 percent further drop to 199 reference level if downside materializes
• A 260 stop allows trade to breathe through dead-cat bounce scenario; tightening stop to 237 or 240 would guarantee stop-out during typical basing pattern resolution
• Exiting entire non-core position caps upside recovery at zero and converts well-structured risk reduction into full capitulation at basing pattern lows
• Oracle down 53 percent and Palantir trading at elevated multiples being audited suggest limited superior deployment alternatives in tech sector
• Catalyst stack including 2nm mainframe, HRL quantum acquisition, Diraq data center deployment, and Susquehanna price target raise provides 12 to 24 month optionality for retained core position
• Basing pattern has been developing for six weeks with ceiling at 242.50 and current price at 233.87
• No Fed cuts priced, hawkish regime, and AI multiple compression risk across sector reduces marginal case for selling IBM to deploy capital elsewhere
• Institutional positioning dominated by constructive forward-looking narratives with zero IBM-specific negative headlines provides tactical floor
• Neutral analyst's wait-and-see approach leaves exposure to downside scenario statistically favored by deteriorating fundamentals while capital remains at risk of breakdown below 227 Bollinger lower band

→ vs aggressive: Full exit of entire non-core position constitutes recklessness, not conviction—capping upside recovery at zero if IBM defends basing pattern and grinds higher through 242.50 ceiling on real volume, converting well-structured risk reduction into full capitulation that has documented habit of marking lows

→ vs aggressive: Tightening stop to 237 or 240 below 242.50 engineers guaranteed stop-out in exact scenario where basing patterns typically resolve—a test of underside of former support producing quick move into 240s before reversing; 260 stop is relatively tight invalidation in context of six-week basing pattern

→ vs aggressive: Dismissal of 2.87 percent dividend yield as inadequate is analytically flawed—2.87 percent on $220 billion market cap enterprise represents real cash returning quarterly, backed by $12 billion FCF with coverage at 1.8 times, compounding annually

→ vs aggressive: Treating IBM like a leveraged roll-up approaching covenant trouble overstates risk—$16+ billion EBITDA and $12 billion FCF with decades of debt service history means net debt to EBITDA at 3.3 times is manageable, not distressed; risk is margin compression and goodwill impairment, not bankruptcy

→ vs aggressive: Dismissing catalyst stack (2nm mainframe, HRL quantum, Diraq deployment, Susquehanna raise) as irrelevant for 12 months is analytically sloppy—selling entire position bets with certainty none of these materialize within planning horizon, which is not analysis but hubris

→ vs aggressive: Concluding institutional positioning is irrelevant based on weak sentiment and zero Reddit footprint does not follow—constructive institutional narrative and zero negative headlines in window means catalysts are providing a floor the full-exit thesis assumes won't hold

→ vs neutral: Wait-and-see approach is intellectually honest but not actionable—capital sitting in IBM at 233.87 while waiting for 50 SMA reclaim is exposed to breakdown below 227 Bollinger lower band that no one is pricing in real time, and indecisiveness has its own risk profile

Execute SELL with 50-60% trim of non-core tactical exposure; retain 40-50% as income sleeve; stop at $245-$248; full exit if price closes below $227 Bollinger lower band.

• Current price $233.87; RSI 27-to-49 recovery and MACD histogram crossed positive indicate basing pattern, not confirmed downtrend
• ATR halved from $16 to $7.65 showing volatility compression consistent with basing, not distribution
• Conservative analyst's $260 stop is 11% above current price—too wide given 50 SMA overhead resistance at $242.50
• Trim 50-60% of non-core tactical exposure (more aggressive than trader's 30-50% range); retain 40-50% as income sleeve only
• Stop at $245-$248 tightens exposure; $245-$248 range captures 50 SMA reclaim for re-evaluation without conceding 15% give-back
• $227 Bollinger lower band is the explicit breakdown level that converts trim into full exit—neither aggressive nor conservative analyst named this level
• Catalyst stack (2nm mainframe, HRL quantum acquisition, Diraq deployment, Susquehanna price target) is not a near-term re-rating story; institutional sentiment confidence is 'low'
• 2.87% dividend yield is real cash but not a reason to maintain directional exposure in a structurally broken chart
• Conservative analyst's dividend/FCF/catalyst defense is built on two non-differentiating pillars for IBM and one materially uncertain pillar

→ vs aggressive: Binary full liquidation ignores the basing pattern evidence (RSI 27-to-49, MACD positive cross, ATR compression from $16 to $7.65); absence of fresh selling defines basing, not broken floor.

→ vs conservative: $260 stop is not tight at 11% above $233.87 when 50 SMA resistance sits at $242.50; stop at $245-$248 captures dead-cat bounce re-evaluation while actually being tighter without being punitive.

→ vs conservative: Catalyst stack is not the solution—it is the problem; 2nm mainframe defends existing revenue, HRL quantum is option value with no 12-month impact, Diraq is one customer, and Susquehanna raise included explicit 'word of caution' about back-end-loaded catalysts with low-confidence institutional signals.

→ vs conservative: Retaining 50% of non-core position in a stock below both moving averages is not meaningful optionality—it is exposure with extra steps.